Profilo
Mr. Anthony Raeside is a Chief Research Officer at Evaluate Ltd.
He leads the firm's analyst teams, currently numbering over 95 staff globally, providing life science sector analysis and commercial insight into the biotechnology, pharmaceutical and medical device industries.
He is an Economics graduate of the London School of Economics and Political Science.
Precedenti posizioni note di Anthony Raeside
Società | Posizione | Fine |
---|---|---|
Evaluate Ltd.
Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Direttore della Ricerca - Azioni | 01/02/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Evaluate Ltd.
Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Finance |
- Borsa valori
- Insiders
- Anthony Raeside